Humanities
Skip to main content Skip to main navigation menu Skip to site footer
  • Register
  • Login
  • Menu
  • Home
  • Current
  • Archives
  • Announcements
  • About
    • About the Journal
    • Submissions
    • Editorial Team
    • Privacy Statement
    • Contact
  • Register
  • Login

Journal of Education, Health and Sport

Reviewing the current treatment approaches for vitiligo – analysis of literature
  • Home
  • /
  • Reviewing the current treatment approaches for vitiligo – analysis of literature
  1. Home /
  2. Archives /
  3. Vol. 49 No. 1 (2023) /
  4. Review Articles

Reviewing the current treatment approaches for vitiligo – analysis of literature

Authors

  • Daniel Ślusarczyk Military Medical Academy Memorial Teaching Hospital – Central Veterans’ Hospital, ul. Stefana Żeromskiego 113, 90-549 Łódź, Poland https://orcid.org/0009-0000-3338-976X
  • Bartłomiej Żmuda Norbert Barlicki Memorial Teaching Hospital No.1 of the Medical University of Lodz, ul. Stefana Kopcińskiego 22, 90-153 Łódź, Poland https://orcid.org/0009-0005-6290-0455
  • Wiktoria Jakubowska Faculty of Medicine, Medical University of Lodz, al. Tadeusza Kościuszki 4, 90-419 Łódź, Poland https://orcid.org/0009-0008-9290-503X
  • Piotr Pisera Faculty of Medicine, Medical University of Lodz, al. Tadeusza Kościuszki 4, 90-419 Łódź, Poland https://orcid.org/0009-0002-7086-7307
  • Aleksandra Kiełkowicz Central Clinical Hospital of Medical University of Lodz, ul. Pomorska 251, 92-213 Łódź, Poland https://orcid.org/0009-0003-7837-0925
  • Zuzanna Popińska Faculty of Medicine, Comenius University Bratislava Špitálska 24, 813 72 Bratislava, Slovakia https://orcid.org/0000-0002-8224-6770
  • Filip Pactwa Faculty of Medicine, Medical University of Lodz, al. Tadeusza Kościuszki 4, 90-419 Łódź, Poland https://orcid.org/0000-0002-9559-5072
  • Michał Żuberek Faculty of Medicine, Nicolaus Copernicus University in Torun, Collegium Medicum in Bydgoszcz, Jagiellonska 13, 85-067 Bydgoszcz https://orcid.org/0009-0008-2358-6784

DOI:

https://doi.org/10.12775/JEHS.2023.49.01.001

Keywords

Vitiligo, Therapeutics, Molecular Targeted Therapy

Abstract

Introduction:

Vitiligo is a relatively common systemic, idiopathic disease within the spectrum of pigmentary disorders. Clinically, it presents as depigmented patches on the skin, resulting from the loss or dysfunction of melanocytes. Despite not impacting life expectancy, vitiligo should not be perceived merely as a cosmetic defect, given its potential to burden daily life and the frequent experiences of stigmatization by patients.

Aim of the study:

The aim of this study was to summarize the existing knowledge regarding the treatment of vitiligo. The current treatments in practice, alongside potential new methods, were summarized and described.

Materials and methods:

The literature available in the PubMed database was reviewed using the following keywords: “Vitiligo”, “Vitiligo treatment”, “Vitiligo new treatment methods”, “Targeted therapies for vitiligo”.

Conclusions:

Vitiligo is a multifactorial and still inadequately understood disorder, leading to a lack of fully safe and effective treatment. As in the management of other diseases, there should be a push for highly personalized treatments for patients. This approach takes into account the differences among patients and ensures a better chance of a positive clinical response. To achieve this goal, it's necessary to explore new treatment methods and expand ongoing research efforts. Also, raising awareness of vitiligo is key to increasing acceptance, support and understanding for those affected by the disease.

References

Barman S. Switra and its treatment in Veda. Ancient Science of Life. AVP Research Foundation. 1995;15(1):71–74. India.

Singh G, Ansari Z, Dwivedi RN. Letter: Vitiligo in ancient Indian medicine. Arch Dermatol. 1974 Jun;109(6):913.

https://doi.org/10.1001/archderm.1974.01630060081032

Bergqvist C, Ezzedine K. Vitiligo: A Review. Dermatology. S. Karger AG. 2020;236(6):571–92.

https://doi.org/10.1159/000506103

Lai YC, Yew YW, Kennedy C, Schwartz RA. Vitiligo and Depression: A Systematic Review and Meta-Analysis of Observational Studies. Br J Dermatol. 2017;177:708–18.

https://doi.org/10.1111/bjd.15199

Placek W, Czajkowski R, Chabior A. Bielactwo nabyte. Dermatologia Praktyczna. 2009;3:9-18. Poland.

Frisoli ML, Essien K, Harris JE. Vitiligo: Mechanisms of Pathogenesis and Treatment. Annu Rev Immunol. 2020;38.

https://doi.org/10.1146/annurev-immunol-100919-023531

Van Geel N, Speeckaert R, Melsens E, Toelle SP, Speeckaert M, De Schepper S, et al. The distribution pattern of segmental vitiligo: Clues for somatic mosaicism. Br J Dermatol. 2013;168(1):56–64.

https://doi.org/10.1111/bjd.12013

Lerner AB. Part V: Clinical Applications of Psoralens, and Related Materials: Vitiligo From the Section of Dermatology, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut. J Invest Dermatol. 1959;32:285–308.

https://doi.org/10.1038/jid.1959.49

Basnet B, Bhushan A, Khan R, Kumar G, Sharma VK, Sharma A, et al. Plasma & urinary catecholamines & urinary vanillylmandelic acid levels in patients with generalized vitiligo. Indian J Med Res. 2018;147(4):384.

https://doi.org/10.4103/ijmr.IJMR_657_16

Nellhaus G. Acquired unilateral vitiligo and poliosis of the head and subacute encephalitis with partial recovery. Neurology (1970) 20(10):965.

https://doi.org/10.1212/wnl.20.10.965

Sharquie KE, Assaf F. Sweating in vitiligo in relation to electrical skin resistance. Clin Exp Dermatol. 1985;10:598–9.

https://doi.org/10.1111/j.1365-2230.1985.tb00632.x

Harris JE. Cellular stress and innate inflammation in organ-specific autoimmunity: Lessons learned from vitiligo. Immunol Rev. 2016;269(1):11–25.

https://doi.org/10.1111/imr.12369

Van den Wijngaard R, Wankowicz-Kalinska A, Le Poole C, Tigges B, Westerhof W, Das P. Local Immune Response in Skin of Generalized Vitiligo Patients. Lab Investig. 2000;80:1299–309.

https://doi.org/10.1038/labinvest.3780138

Chen GY, Nuñez G. Sterile inflammation: Sensing and reacting to damage. Nat Rev Immunol. 2010;10(12):826–837.

https://doi.org/10.1038/nri2873

Wu CS, Yu HS, Chang HR, Yu CL, Yu CL, Wu BN. Cutaneous blood flow and adrenoceptor response increase in segmental-type vitiligo lesions. J Dermatol Sci. 2000; 23(1):53–62.

https://doi.org/10.1016/S0923-1811(99)00090-0

Van Geel N, Mollet I, Brochez L, Dutré M, De Schepper S, Verhaeghe E, et al. New insights in segmental vitiligo: case report and review of theories. Br J Dermatol. 2012;166:240–6.

https://doi.org/10.1111/j.1365-2133.2011.10650.x

Gauthier Y, Cario-Andre M, Lepreux S, Pain C, Taïeb A . Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo. Br J Dermatol. 2003;148(1):95–101.

https://doi.org/10.1046/j.1365-2133.2003.05024.x

Puri N, Mojamdar M, Ramaiah A. In Vitro Growth Characteristics of Melanocytes Obtained From Adult Normal and Vitiligo Subjects. J Invest Dermatol. 1987;88:434–8.

https://doi.org/10.1111/1523-1747.ep12469795

Maresca V, Roccella M, Roccella F, Camera E, Del Porto G, Passi S, et al. Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. J Invest Dermatol. 1997;109(3):310–13.

https://doi.org/10.1111/1523-1747.ep12335801

Czajkowski R, Męcińska-Jundziłł K. Current aspects of vitiligo genetics. Postep Dermatol Alergol. 2014;31:247-255.

https://doi.org/10.5114/pdia.2014.43497

Böhm M, Schunter J, Fritz K et al. S1 Guideline: Diagnosis and therapy of vitiligo.

J Dtsch Dermatol Ges. 2022;20(3):365-378.

https://doi.org/10.1111/ddg.14713

Taieb A, Picardo M. Clinical practice. Vitiligo. N Engl J Med. 2009;360:160-169.

https://doi.org/10.1056/NEJMcp0804388

Ezzedine K, Lim HW, Suzuki T, Katayama I, Hamzavi I, Lan CC, et al. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res. 2012;25:E1-13.

https://doi.org/10.1111/j.1755-148X.2012.00997.x

Masuria BL, Batra A, Kothiwala RK, Khuller R. Topical mometasone furoate for the treatment of childhood vitiligo. Indian Journal of Dermatology, Venereology, and Leprology. 1999;65(5):219.

Taieb AV, Alomar A, Böhm M, Dell’Anna ML, De Pase A, Eleftheriadou V, Ezzedine K, Gauthier Y, Gawkrodger DJ, Jouary T, Leone G. Guidelines for the management of vitiligo: the European Dermatology Forum consensus. British Journal of Dermatology. 2013;168(1):5-19.

Wazir SM, Paracha MM, Khan SU. Efficacy and safety of topical mometasone furoate 0.01% vs. tacrolimus 0.03% and mometasone furoate 0.01% in vitiligo. Journal of Pakistan Association of Dermatology. 2016;20(2):89-92.

Njoo MD, Spuls P, Bos JT, Westerhof W, Bossuyt PM. Nonsurgical repigmentation therapies in vitiligo: meta-analysis of the literature. Archives of dermatology. 1998;134(12):1532-40.

Felsten LM, Alikhan A, Petronic-Rosic V. Vitiligo: A comprehensive overview: Part II: Treatment options and approach to treatment. Journal of the American Academy of Dermatology. 2011;65(3):493-514.

https://doi.org/10.1016/j.jaad.2010.10.043

Lubaki LJ, Ghanem G, Vereecken P, Fouty E, Benammar L, Vadoud-Seyedi J, Dell’Anna ML, Briganti S, Picardo M, Heenen M. Time-kinetic study of repigmentation in vitiligo patients by tacrolimus or pimecrolimus. Archives of dermatological research. 2010;302(2):131-7.

https://doi.org/10.1007/s00403-009-0973-3

Lepe V, Moncada B, Castanedo-Cazares JP, Torres-Alvarez MB, Ortiz CA, Torres-Rubalcava AB. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. Archives of dermatology. 2003;139(5):581-5.

https://doi.org/10.1001/archderm.139.5.581

Karagaiah P, Valle Y, Sigova J, Zerbinati N, Vojvodic P, Parsad D, Schwartz RA, Grabbe S, Goldust M, Lotti T. Emerging drugs for the treatment of vitiligo. Expert Opin Emerg Drugs. 2020;25(1):7-24.

https://doi.org/10.1080/14728214.2020.1712358

Fa Y, Lin Y, Chi XJ, Shi WH, Wang JL, Guo X, Geng JH, Liu HX, Zhang FR. Treatment of vitiligo with 308‐nm excimer laser: our experience from a 2‐year follow‐up of 979 Chinese patients. Journal of the European Academy of Dermatology and Venereology. 2017;31(2):337-40.

https://doi.org/10.1111/jdv.13917

Wu CS, Hu SC, Lan CC, Chen GS, Chuo WH, Yu HS. Low‐energy heliumneon laser therapy induces repigmentation and improves the abnormalities of cutaneous microcirculation in segmental‐type vitiligo lesions. The Kaohsiung journal of medical sciences. 2008;24(4):180-9.

https://doi.org/10.1016/S1607-551X(08)70115-3

Kanwar AJ, Mahajan R, Parsad D. Low-dose oral mini-pulse dexamethasone therapy in progressive unstable vitiligo. Journal of cutaneous medicine and surgery. 2013;17(4):259-68.

https://doi.org/10.2310/7750.2013.1205

Madarkar M, Ankad BS, Manjula R. Comparative study of safety and efficacy of oral betamethasone pulse therapy and azathioprine in vitiligo. Clinical Dermatology Review. 2019;3(2):121.

https://doi.org/10.4103/CDR.CDR_13_18

Fraczek A, Kasprowicz-Furmańczyk M, Placek W, Owczarczyk-Saczonek A. Surgical Treatment of Vitiligo. Int. J. Environ. Res. Public Health 2022;19,4812.

https://doi.org/10.3390/ijerph19084812

Singh A, Kanwar AJ, Parsad D, Mahajan R. Randomized controlled study to evaluate the effectiveness of dexamethasone oral minipulse therapy versus oral minocycline in patients with active vitiligo vulgaris. Indian Journal of Dermatology, Venereology, and Leprology. 2014;80(1):29.

https://doi.org/10.4103/0378-6323.125479

Singh H, Kumaran M, S, Bains A, Parsad D: A Randomized Comparative Study of Oral Corticosteroid Minipulse and Low-Dose Oral Methotrexate in the Treatment of Unstable Vitiligo. Dermatology 2015;231:286-290.

https://doi.org/10.1159/000433424

Taneja A, Kumari A, Vyas K, Khare AK, Gupta LK, Mittal AK. Cyclosporine in treatment of progressive vitiligo: An open-label, single-arm interventional study. Indian J Dermatol Venereol Leprol 2019;85:528-31

https://doi.org/10.4103/ijdvl.IJDVL_656_18

Rothstein B, Joshipura D, Saraiya A, et al. Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib. J Am Acad Dermatol. 2017;76(6):1054-1060.

https://doi.org/10.1016/j.jaad.2017.02.049

Vanderweil SG, Amano S, Ko WC, et al. A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo. J Am Acad Dermatol. 2017;76(1):150–151.

https://doi.org/10.1016/j.jaad.2016.06.015

Lim HW, Grimes PE, Agbai O, Hamzavi I, Henderson M, Haddican M, et al. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial. JAMA Dermatol. 2015;151(1):42–50.

https://doi.org/10.1001/jamadermatol.2014.1875

Taieb AV, Alomar A, Böhm M, Dell’Anna ML, De Pase A, Eleftheriadou V, Ezzedine K, Gauthier Y, Gawkrodger DJ, Jouary T, Leone G. Guidelines for Accepted Manuscript the management of vitiligo: the European Dermatology Forum consensus. British Journal of Dermatology. 2013 Jan;168(1):5-19.

https://doi.org/10.1111/j.1365-2133.2012.11197.x

Grimes PE, Miller MM. Vitiligo: Patient stories, self-esteem, and the psychological burden of disease. International journal of women's dermatology. 2018;4(1):32-7.

https://doi.org/10.1016/j.ijwd.2017.11.005

Downloads

  • PDF

Published

2023-12-30

How to Cite

1.
ŚLUSARCZYK, Daniel, ŻMUDA, Bartłomiej, JAKUBOWSKA, Wiktoria, PISERA, Piotr, KIEŁKOWICZ, Aleksandra, POPIŃSKA, Zuzanna, PACTWA, Filip and ŻUBEREK, Michał. Reviewing the current treatment approaches for vitiligo – analysis of literature. Journal of Education, Health and Sport. Online. 30 December 2023. Vol. 49, no. 1, pp. 11-26. [Accessed 20 May 2025]. DOI 10.12775/JEHS.2023.49.01.001.
  • ISO 690
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
Download Citation
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

Issue

Vol. 49 No. 1 (2023)

Section

Review Articles

License

Copyright (c) 2023 Daniel Ślusarczyk, Bartłomiej Żmuda, Wiktoria Jakubowska, Piotr Pisera, Aleksandra Kiełkowicz, Zuzanna Popińska, Filip Pactwa, Michał Żuberek

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0

Stats

Number of views and downloads: 453
Number of citations: 0

Search

Search

Browse

  • Browse Author Index
  • Issue archive

User

User

Current Issue

  • Atom logo
  • RSS2 logo
  • RSS1 logo

Information

  • For Readers
  • For Authors
  • For Librarians

Newsletter

Subscribe Unsubscribe

Tags

Search using one of provided tags:

Vitiligo, Therapeutics, Molecular Targeted Therapy
Up

Akademicka Platforma Czasopism

Najlepsze czasopisma naukowe i akademickie w jednym miejscu

apcz.umk.pl

Partners

  • Akademia Ignatianum w Krakowie
  • Akademickie Towarzystwo Andragogiczne
  • Fundacja Copernicus na rzecz Rozwoju Badań Naukowych
  • Instytut Historii im. Tadeusza Manteuffla Polskiej Akademii Nauk
  • Instytut Kultur Śródziemnomorskich i Orientalnych PAN
  • Instytut Tomistyczny
  • Karmelitański Instytut Duchowości w Krakowie
  • Ministerstwo Kultury i Dziedzictwa Narodowego
  • Państwowa Akademia Nauk Stosowanych w Krośnie
  • Państwowa Akademia Nauk Stosowanych we Włocławku
  • Państwowa Wyższa Szkoła Zawodowa im. Stanisława Pigonia w Krośnie
  • Polska Fundacja Przemysłu Kosmicznego
  • Polskie Towarzystwo Ekonomiczne
  • Polskie Towarzystwo Ludoznawcze
  • Towarzystwo Miłośników Torunia
  • Towarzystwo Naukowe w Toruniu
  • Uniwersytet im. Adama Mickiewicza w Poznaniu
  • Uniwersytet Komisji Edukacji Narodowej w Krakowie
  • Uniwersytet Mikołaja Kopernika
  • Uniwersytet w Białymstoku
  • Uniwersytet Warszawski
  • Wojewódzka Biblioteka Publiczna - Książnica Kopernikańska
  • Wyższe Seminarium Duchowne w Pelplinie / Wydawnictwo Diecezjalne „Bernardinum" w Pelplinie

© 2021- Nicolaus Copernicus University Accessibility statement Shop